Paroxetine for patients with undifferentiated somatoform disorder: A prospective, open-label, 8-week pilot study
Abstract Background: Forty-eight percent of somatic symptoms encountered in the primary care setting are medically unexplained. Such symptoms have been associated with negative impact on quality of life and with functional impairment. Objective: The aim of this study was to assess the potential util...
Gespeichert in:
Veröffentlicht in: | Current therapeutic research 2008-06, Vol.69 (3), p.221-231 |
---|---|
Hauptverfasser: | , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Schreiben Sie den ersten Kommentar!